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Background/Aims: Epidemiological studies suggest 
that there is a considerable overlap between func-
tional dyspepsia (FD) and irritable bowel syndrome 
(IBS). The aim of this study was to examine con-
current gastrointestinal symptoms in FD and IBS. 
Methods: A total of 186 college students filled out a 
questionnaire regarding whether they had uninvesti-
gated dyspepsia (UD, FD without endoscopic exami-
nation) and IBS based on Rome-II criteria. Gastroin-
testinal symptoms were measured using the Gastroin-
testinal Symptom Rating Scale (GSRS) questionnaire. 
Results: A total of 181 students (98 males, mean 
age 24.6 years) completed both questionnaires. The 
prevalence of UD, IBS, and UD+IBS overlap was 12 
(6.7%), 40 (22.1%), and 8 (4.4%), respectively. A sig-
nificant UD+IBS overlap was observed (66.7% IBS in 
UD, 20.0% UD in IBS). Reflux scores of GSRS in eit-
her UD or IBS were significantly greater than in those 
without. Gastroesophageal reflux disease (GERD), de-
fined as weekly occurring moderate symptoms of 
heartburn and/or acid regurgitation and evaluated us-
ing the GSRS, was found in 16 (8.8%) of the sub-
jects. The prevalence of IBS was significantly higher 
in GERD patients than in non-GERD patients (50.0% 
vs 19.4%). Conclusions: The considerable overlap 
not only between UD and IBS, but also between 
GERD and IBS, suggests the involvement of common 
pathophysiological disturbances in the two conditions. 
(Gut and Liver 2009;3:192-196)
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INTRODUCTION
    Functional dyspepsia (FD) and irritable bowel syn-
drome (IBS) are two major functional gastrointestinal 
(GI) disorders. Both conditions are determined by hetero-
geneous factors, and FD and IBS are regarded as separate 
entities with unknown etiology; however, several common 
pathophysiological disturbances in FD and IBS have re-
cently been identified, such as visceral hypersensitivity,
1 
and indeed FD coexists in one- to two-thirds of IBS 
subjects.
1-7 Based on such common disturbances, a few 
recent review articles suggested that FD and IBS repre-
sent different manifestations of a single entity.
2,3 Surveys 
of concurrent upper and lower GI symptoms are useful to 
support this idea; however, the overlap of FD and IBS has 
not been examined in Japan.
  The aim of this study was to examine GI symptoms in 
FD and IBS. We conducted a survey of FD and IBS in our 
medical students after a lecture on these diagnoses. The 
severity of various GI symptoms was assessed using the 





    One hundred eighty-six consecutive 5th-year medical 
s t u d e n t s  i n  o u r  c o l l e g e  ( 1 0 0  m a l e s ,  2 4 . 5 ± 3 . 0  y e a r s  o l d )  
were recruited between June 2005 and December 2007. 
T h is  s u r v e y  w a s  c o n d u c t e d  w h e n  s m a l l  g r o u p s  o f  5  o r  6 
students entered our Division of Gastroenterology for 
clinical training. Hori K, et al: FD and IBS   193
Table 1. Demographics of Students Who Completed the 
Survey (n=181) and Prevalence of UD, IBS, and UD+IBS
Demographics Male:Female (%)    98:83 (54:46)
Age (years [SD], range) 24.6±3.1 (21-43)
H. pylori infection (%)   15/181 (8.3)
NSAID user (%)    5/181 (2.8)*
Prevalence UD (%)   12/181 (6.7)
†
  U l c e r - l i k e  ( % )     5 / 1 2  ( 4 1 . 7 )
  D y s m o t i l i t y - l i k e  ( % )     7 / 1 2  ( 5 8 . 3 )
IBS (%)   40/181 (22.1)
  Diarrhea-    26/40 (65.0)
   p r e d o m i n a n t  ( % )
  Constipation-    14/40 (35.0)
   p r e d o m i n a n t  ( % )
UD+IBS overlap (%)    8/181 (4.4)
UD, uninvestigated dyspepsia; IBS, irritable bowel syndrome; 
SD, standard deviation; H. pylori, Helicobacter pylori; NSAID, 
nonsteroidal anti-inflammatory drug.





1)  Helicobacter pylori ( H. pylori)
  To examine the influence of H. pylori on the develop-
ment of FD or IBS, blood was collected, and serum an-
ti-H. pylori immunoglobulin G antibodies were measured 
by an enzyme-linked immunosorbent assay.
2) GSRS
    Students filled out the GSRS questionnaire anony-
mously. GSRS includes 15 questions on a scale of 1 to 7, 
depending on how inconvenient it had been during the 
previous week. A higher score indicates more incon-
venient symptoms. Combination scores among 15 ques-
tions can assess the following five domains: reflux syn-
drome (heartburn and acid regurgitation), abdominal pain 
(stomach ache, gastric hunger pains and nausea), in-
digestion syndrome (gastric borborygmus, gastric bloat-
ing, eructation and increased flatus), diarrhea syndrome 
(diarrhea, loose stools and urgent need to defecate) and 
constipation syndrome (constipation, hard stools and feel-
ing of incomplete evacuation).
8
  The presence of gastroesophageal reflux disease (GERD) 
was also assessed by GSRS. GERD was considered when 
the either heartburn score or acid regurgitation score was 
4 or greater. This condition indicates moderate symptoms 
of heartburn and/or acid regurgitation occurring at least 
once per week, which corresponded to the Montreal defi-




  After the GSRS questionnaire, a small group was given 
an intensive lecture on FD and IBS diagnoses for half an 
hour. These diagnoses were based on Rome II criteria. In 
brief, FD was defined as follows: at least 12 weeks within 
the preceding 12 months of dyspepsia defined as pain or 
discomfort centered in the upper abdomen; no evidence 
of organic disease likely to explain the symptoms; and no 
evidence that dyspepsia is exclusively relieved by defeca-
tion or associated with the onset of a change in stool fre-
quency or stool form.
11 FD was subdivided into symptom 
subgroups, ulcer-like (pain-predominant), dysmotility-like 
(unpleasant or irritating non-painful sensation-predom-
inant) and unspecified (no symptoms of the above) dys-
pepsia. IBS was defined as follows: at least 12 weeks in 
the preceding 12 months of abdominal discomfort or pain 
with two of three features: relieved with defecation; and/ 
or onset associated with a change in defecation frequency; 
and/or onset associated with a change in stool forma-
tion.
12 IBS was also subdivided into symptom subgroups, 
diarrhea-predominant and constipation-predominant IBS.
    Subsequently, students filled out our questionnaire 
about whether they had uninvestigated dyspepsia (UD, 
defined as FD without endoscopic investigation) and IBS 
anonymously. The questionnaire also included age, gender 
and the use of nonsteroidal anti-inflammatory drugs 
(NSAIDs). NSAID users were defined as subjects who 
had taken NSAIDs on at least 3 days over the previous 
week.
  Exclusion criteria from this study were that students 
did not complete both GSRS and our questionnaires.
3. Statistics
  The results are reported as the mean±standard devia-
tion. Fisher’s exact probability test and the Wilcoxon test 
were performed using JMP software (SAS Institute Inc., 
Cary, NC, USA). p＜0.05 was considered significant.
RESULTS
1. Prevalence
    One hundred eighty-one of 186 students completed 
both questionnaires (97.3% response rate). Five students 
were excluded due to incomplete responses to our 
questionnaire. Subject characteristics are summarized in 
Table 1. This survey revealed that 12 (6.7%) and 40 
(22.1%) of 181 subjects had UD and IBS, respectively. H. 
pylori infection was recognized in 15 subjects (8.3%).
  UD coexisted with IBS in 8 (4.4%) subjects. In 12 UD 
subjects, IBS was significantly prevalent than in non-UD 194   Gut and Liver, Vol. 3, No. 3, September 2009
Fig. 1. GSRS scores for (A) UD and (B) IBS. Data are mean and standard deviation values. 
GSRS, Gastrointestinal Symptom Rating Scale; UD, uninvestigated dyspepsia; IBS, irritable bowel syndrome; NS, not significant.
Table 2. The Prevalence of UD, IBS, and UD+IBS in GERD 









UD (%)  9 (5.5) 3 (18.8) NS
  Ulcer-like (%)  2 (1.2) 3 (18.8) 0.0051
  Dysmotility-like (%)  7 (4.2) 0 (0) NS
IBS (%) 32 (19.4) 8 (50.0) 0.0095
  Diarrhea-predominant (%) 22 (13.3) 4 (25.0) NS
  Constipation-predominant (%) 10 (6.1) 4 (25.0) 0.0240
UD+IBS overlap (%)  6 (3.6) 2 (12.5) NS
UD, uninvestigated dyspepsia; IBS, irritable bowel syndrome; 
GERD, gastroesophageal reflux disease; GSRS, Gastrointesti-
nal Symptom Rating Scale; NS, not significant.
subjects (8/12 [66.7%] vs 32/169 [18.9%], p=0.0008). 
Conversely, in 40 IBS subjects, UD was significantly more 
prevalent than in non-IBS subjects (8/40 [20.0%] vs 4/ 
141 [7.1%], p=0.0008).
2. Characteristics
  Demographic comparisons either between UD and non- 
UD cases or between IBS and non-IBS cases showed no 
statistically significant differences in age, sex, H. pylori 
status, and NSAID use (data not shown). Comparisons be-
tween UD+IBS overlap and non-overlap cases showed 
similar results, except a sex difference. Seven (87.5%) of 
8 students with UD+IBS overlap were women, which was 
significantly predominant compared with non-overlap (vs 
76/173 [43.9%], p=0.0247). Also in subdivided IBS, the 
characteristic of constipation-predominant IBS was sig-
nificantly prevalent in women (12/14 [85.7%] vs 71/167 
[42.5%], p=0.0036). 
3. Symptoms
    T h e  s e v e r i t i e s  o f  G I  s y m p t o m s  i n  U D  a n d  I B S  a r e  
shown in Fig. 1. In UD subjects, not only abdominal pain 
but also constipation were significantly more inconvenient 
than in subjects without UD. Also in IBS subjects, not 
only diarrhea and constipation but also abdominal pain 
indicating upper abdominal symptoms (stomach ache, 
gastric hunger pains and nausea) were significantly more 
inconvenient than in non-IBS subjects.
  The reflux scores in subjects with UD or IBS were sig-
nificantly greater than in those without. If GERD was de-
fined as weekly moderate symptoms of heartburn and/or 
acid regurgitation, 16 (8.8%) of 181 subjects were consid-
ered as having GERD estimated by GSRS. In GERD sub-
jects, the prevalence of IBS, especially the constipation 
type of IBS, was significantly greater than in non-GERD 
subjects (Table 2).
  The overlaps among UD, IBS and GERD are shown in 
Fig. 2. GERD coexisted with IBS in 4.4% of our popula-
tion. Not only UD and IBS but also GERD and IBS con-
siderably overlapped.Hori K, et al: FD and IBS   195
Fig. 2. Overlap between UD, IBS, and GERD (as estimated by 
the GSRS) in 181 students. 
UD, uninvestigated dyspepsia; IBS, irritable bowel syndrome; 
GERD, gastroesophageal reflux disease; GSRS, Gastrointestinal
Symptom Rating Scale.
DISCUSSION
  This survey found considerable overlap, not only be-
tween UD and IBS but also between GERD and IBS. 
GERD+IBS overlap rather than FD+IBS overlap has been 
recently highlighted, and this considerable overlap has 
been advocated in several review articles.
13,14 The preva-
lence of IBS in GERD has been reported to be 19-71%, 
and that of GERD in IBS as 11-79%
4,13-17; in this study 
they were 50% and 20%, respectively. A population-based 
study revealed that the prevalence of GERD+IBS overlap 
was 2.8% in men and 4.4% in women, and the authors 
concluded that GERD+IBS overlap did not occur by 
chance, because these rates were greater than the ex-
pected prevalence
15; the prevalence in our population was 
similar (4.4%). A systemic review showed that the preva-
lence of IBS in the non-GERD population was estimated 
t o  b e  o n l y  5 . 1 % ,  m u c h  l o w e r  t h a n  i n  t h e  w h o l e  p o p -
ulation, 11.2%,
13 indicating that IBS could be relatively 
uncommon in the absence of GERD, and vice versa.
  The reason for the strong overlap between GERD and 
IBS remains unknown. Two main hypotheses have been 
proposed as follows: GERD and IBS are two distinct dis-
orders with a common pathophysiologic process; and IBS 
symptoms are part of GERD manifestations.
14 GERD is 
defined as a condition that develops when the reflux of 
stomach contents causes irritating symptoms and/or com-
plications,
10 and is an organic disorder; however, general 
GERD studies might often include functional disorders, 
such as functional heartburn. Unfortunately the preva-
lence of IBS was reported to be similar in patients with 
functional heartburn vs non-erosive reflux disease (NERD) 
(46% vs 50%),
16 or in patients with NERD probably in-
cluding functional heartburn vs erosive GERD (35% vs 
36%)
17; therefore, GERD symptoms may be generated by 
an “irritable gut” as a common pathophysiologic process 
rather than the greater extent of reflux or mucosal injury.
    Common pathophysiological processes have been re-
ported in the overlap of FD and IBS, such as visceral hy-
persensitivity and delayed gastric emptying.
2,3 In a visceral 
hypersensitivity study, patients with FD+IBS overlap were 
found to have hypersensitivity to gastric distension com-
pared to those with FD alone (44% vs 28%).
1 In a gastric 
emptying study, gastric emptying rates were lower in IBS 
p a t i e n t s  t h a n  i n  c o n t r o l s  ( 3 3 % / h  v s  4 0 % / h ) ,  w h e r e a s  
those in patients with IBS alone were similar to those in 
controls (37%/h vs 40%/h, but 31%/h in IBS with dys-
pepsia).
5 Although these results suggest the existence of 
c o m m o n  d i s t u r b a n c e s  b e t w e e n  F D  a n d  I B S ,  t h e s e  s i g -
n ifican t b u t lim ite d  d ata se em  to b e w e ak  if F D  an d  IB S 
are regarded as a single entity. Our results also appeared 
similar in the significant but limited overlap. Rather, the 
possible existence of a novel entity between FD and IBS 
should be addressed, such as irritable gut. The prevalence 
o f  U D + I B S  o v e r l a p  w a s  r e p o r t e d  t o  b e  5 . 0 %  i n  a n  o u t -
patient population,
6 and 4.9% in a GERD population,
7 
sim ilar to 4.4%  in  th is stu dy. Significant fem ale predom-
inance in the overlap was found in our study, and a few 
articles have shown a similar result.
1
  A high prevalence of IBS (22.1%) was found in this 
study. The prevalence of IBS in population-based studies 
is around 10%.
4 IBS mainly affects adolescents and youn-
ger adults, and IBS development in this population is 
about twice as frequent as in a presenile population.
18 
Hence, the high prevalence seems to be due to the 
younger age of our study subjects. Our result of sig-
nificant female predominance in constipation-predominant 
IBS is the same as in previous studies.
19
  I n  c o n tra st , a  lo w  p re v a le n c e  o f  U D  ( 6 .7 % )  w a s f o u n d 
i n  t h i s  s t u d y .  T h e  p r e v a l e n c e  o f  U D  i n  p o p u l a t i o n - b a s e d  
studies is around 24% using Rome II criteria.
20 Although 
the peak prevalence of FD was noted at ages 40-49 in 
Japan, the prevalence at a younger age of 15-29 stayed 
about the same (about 14% vs 13%).
21 Since a cross-na-
tional study pointed out that the prevalence of upper GI 
symptoms in Japan was the lowest (9.4%) of the 7 coun-
tries (28.1% on average),
22 Japanese may have fewer 
symptoms of dyspepsia.196   Gut and Liver, Vol. 3, No. 3, September 2009
  In summary, significant UD+IBS overlap was observed 
in 4.4% with female predominance. Subjects with GERD 
symptoms more frequently had IBS than those without. 
Considerable overlap between UD and IBS or between 
GERD and IBS could indicate the involvement of common 
pathophysiological disturbances. Investigating such com-
mon disorders could be a breakthrough to identify the 
pathogeneses.
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